Decode Health Biomarker Discovery Platform Advances Findings in MS and NMO
DecodeHealth2024-03-27T13:53:07-05:00Decode Health deployed its biomarker discovery platform, incorporating machine learning, to provide new insights into multiple sclerosis (MS) and neuromyelitis optica (NMO). The Decode platform identified disease-specific RNA biomarkers and connections between RNA expression [read more...]